HLA-DP allele-specific T cell responses to beryllium account for DP-associated susceptibility to chronic beryllium disease

被引:77
|
作者
Lombardi, G
Germain, C
Uren, J
Fiorillo, MT
du Bois, RM
Jones-Williams, W
Saltini, C
Sorrentino, R
Lechler, R
机构
[1] Hammersmith Hosp, ICSM, Dept Immunol, London W12 0NN, England
[2] Univ La Sapienza, Dept Cell Biol & Dev, I-00161 Rome, Italy
[3] Royal Brompton Hosp, London SW3 6LY, England
[4] Univ Wales, Coll Med, Dept Med, Cardiff CF1 3NS, S Glam, Wales
[5] Univ Roma Tor Vergata, Div Res Dis, Rome, Italy
[6] L Spallanzani Hosp, Inst Res & Clin Care, Rome, Italy
来源
JOURNAL OF IMMUNOLOGY | 2001年 / 166卷 / 05期
关键词
D O I
10.4049/jimmunol.166.5.3549
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Occupational exposure to small molecules, such as metals, is frequently associated with hypersensitivity reactions, Chronic beryllium (Be) disease (CBD) is a multisystem granulomatous disease that primarily affects the lung, and occurs in similar to3% of individuals exposed to this element. Immunogenetic studies have demonstrated a strong association between CBD and possession of alleles of HLA-DP containing glutamic acid (Glu) at position 69 in the HLA-DP beta -chain. T cell clones were raised from three patients with CBD in whom exposure occurred 10 and 30 years previously. Of 25 Be-specific clones that were obtained, all were restricted by HLA-DP alleles with Glu at DP beta 69, Furthermore, the proliferative responses of the clones were absolutely dependent upon DP beta Glu(69) in that a single amino acid substitution at this position abolished the response. As befits a disease whose pathogenesis involves a delayed type hypersensitivity response, the large majority of Be-specific clones secreted IFN-gamma (Th1) and little or no IL-4 (Th2) cytokines, This study provides insights into the molecular basis of DP2-associated susceptibility to CBD.
引用
收藏
页码:3549 / 3555
页数:7
相关论文
共 45 条
  • [1] Chronic beryllium disease: T cell recognition of a metal presented by HLA-DP
    Fontenot, AP
    Newman, LS
    Kotzin, BL
    [J]. CLINICAL IMMUNOLOGY, 2001, 100 (01) : 4 - 14
  • [2] Beryllium presentation to CD4+ T cells underlies disease-susceptibility HLA-DP alleles in chronic beryllium disease
    Fontenot, AP
    Torres, M
    Marshall, WH
    Newman, LS
    Kotzin, BL
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (23) : 12717 - 12722
  • [3] Molecular basis of HLA-DP-associated susceptibility to beryllium disease
    Lombardi, G
    Uren, J
    Jones-Williams, W
    Saltini, C
    Lechler, R
    [J]. HLA - GENETIC DIVERSITY OF HLA FUNCTIONAL AND MEDICAL IMPLICATION, PROCEEDINGS OF THE TWELFTH INTERNATIONAL HISTOCOMPATIBILITY WORKSHOP AND CONFERENCE (12TH IHWC), VOL II: CONFERENCE, 1997, : 709 - 711
  • [4] Molecular basis of HLA-DP-associated susceptibility to beryllium disease
    Lombardi, G
    Uren, J
    JonesWilliams, W
    Saltini, C
    Lechler, R
    [J]. HUMAN IMMUNOLOGY, 1996, 47 (1-2) : O135 - O135
  • [5] HLA-DP TYPING BY DNA AMPLIFICATION AND HYBRIDIZATION WITH ALLELE-SPECIFIC OLIGONUCLEOTIDES
    ANGELINI, G
    BUGAWAN, T
    DELFINO, L
    ERLICH, H
    FERRARA, GB
    [J]. HUMAN IMMUNOLOGY, 1988, 23 (02) : 77 - 77
  • [6] HLA-DP restricted CD4+ T cells from the lungs of patients with chronic beryllium disease
    Fontenot, AP
    Vollmer, M
    Newman, LS
    Kotzin, BL
    [J]. FASEB JOURNAL, 2000, 14 (06): : A1161 - A1161
  • [7] HLA-DR and -DP specific T cell clones from patients with chronic beryllium disease.
    Liang, J
    Lee, J
    Lee, CW
    Rossman, M
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1999, 159 (03) : A213 - A213
  • [8] Beryllium binding to HLA-DP molecule carrying the marker of susceptibility to berylliosis glutamate β69
    Amicosante, M
    Sanarico, N
    Berretta, F
    Arroyo, J
    Lombardi, G
    Lechler, R
    Colizzi, V
    Saltini, C
    [J]. HUMAN IMMUNOLOGY, 2001, 62 (07) : 686 - 693
  • [9] HLA-DP expression and sensitivity to lysis by an HLA-DP specific T cell clone of fresh leukemic blasts.
    Ibisch, C
    Gallot, G
    Vivien, R
    Hallet, MM
    Milpied, N
    Garand, R
    Vie, H
    [J]. EXPERIMENTAL HEMATOLOGY, 1997, 25 (08) : 563 - 563
  • [10] HLA-DP expression and sensitivity to lysis by an HLA-DP specific T cell clone of fresh leukemic blasts.
    Ibisch, C
    Gallot, G
    Vivien, R
    Hallet, MM
    Milpied, N
    Garand, R
    Vié, H
    [J]. BLOOD, 1998, 92 (10) : 59B - 59B